Michael Wilson - 31 Mar 2025 Form 4 Insider Report for CELESTICA INC (CLS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Apr 2025, 16:16:45 UTC
Prior SEC filing
08 Jan 2025
Next SEC filing
10 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tracy Connelly McGilley, attorney-in-fact

Key filing fact

Michael Wilson filed Form 4 for CELESTICA INC (CLS) on 02 Apr 2025.

Key facts

  • This page summarizes Michael Wilson's Form 4 filing for CELESTICA INC (CLS).
  • 5 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2025, 16:16.

Change

  • Previous filing in this sequence was filed on 08 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLS transaction

Common Shares

Options Exercise

Transaction value
$0
Shares
+5,717
Change %
+320%
Price
$0.000000
Shares after
7,501
Date
31 Mar 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLS transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-2,517
Change %
-100%
Price
$0.000000
Shares after
0
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
2,517
Exercise price
Footnotes
F1, F2
CLS transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-2,440
Change %
-50%
Price
$0.000000
Shares after
2,439
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
2,440
Exercise price
Footnotes
F1, F3
CLS transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$0
Shares
-760
Change %
-33%
Price
$0.000000
Shares after
1,520
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
760
Exercise price
Footnotes
F1, F4
CLS transaction Derivative

Deferred Share Units

Award

Transaction value
$0
Shares
+1,300
Change %
+0.46%
Price
$0.000000
Shares after
284,431
Date
31 Mar 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
1,300
Exercise price
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.

Footnote F2

On March 31, 2022, the reporting person was granted 7,550 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Footnote F3

On March 31, 2023, the reporting person was granted 7,318 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Footnote F4

On March 31, 2024, the reporting person was granted 2,280 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Footnote F5

Each deferred share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to be (a) a director of the Issuer or (b) an employee of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .